AAO 2023: Phase 3 LYNX-1 trial: Phentolamine ophthalmic solution improves low-contrast night vision
November 2nd 2023Researchers conducted a study on 145 patients with night vision problems, testing the effects of 0.75% phentolamine ophthalmic solution. The trial demonstrated substantial improvement in visual acuity on both evaluation days.
Read More
World Sight Day 2023: Focusing on preservation of vision in the workplace
October 11th 2023World Sight Day on October 12 highlights the vital role of eye care in workplaces. The International Agency for the Prevention of Blindness urges employers to prioritize eye health, aiming to enhance well-being, safety, and productivity.
Read More
Rapid point-of-care identification of aspergillus species in microbial keratitis
October 3rd 2023A rapid lateral-flow device shows high sensitivity and specificity in identifying Aspergillus species in corneal samples, aiding in diagnosing microbial keratitis. The device, coupled with ratiometric analysis, proves robust and cost-effective, potentially revolutionizing MK diagnosis, especially in low-resource settings
Read More
Proceed with caution regarding AI-generated ophthalmic references and abstracts
August 19th 2023Clinicians should be alert to the fact that while artificial intelligence (AI) is capable of generating ideas and references, it is crucial to thoroughly vet and fact-check any medical research content that AI produces.
Read More